Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.01 | 31.59 |
| PEG Ratio (TTM) | 0.72 | 75.43 |
| P/S Ratio (TTM) | N/A | 7.17 |
| P/B Ratio (TTM) | 0.06 | 6.25 |
| P/FCF Ratio (TTM) | 9.97 | 5.42 |
| Price to 5YR AVG Earnings Ratio | -0.40 | 168.71 |
| Price to 5YR AVG FCF Ratio | -14.04 | -33.07 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.81% | 0.86% |
| ROE (TTM) | -1.01% | 8.14% |
| Net Profit Margin (TTM) | N/A | -15.88% |
| ROIC 5YR AVG | -4.38% | 4.01% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -15.01% | 32.78% | 50.93% |
| Revenue | N/A | -63.14% | -37.88% |
| Net Income | -17.06% | -41.93% | 4.21% |
| Cash Flow | -31.05% | -72.04% | -3,878.22% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.68 | 1.17 |
| Quick Ratio (TTM) | 5.68 | 0.95 |
| D/E Ratio (TTM) | 0.15 | 1.28 |
| Interest Coverage (TTM) | -4.42 | 7.26 |
| Piotroski F-Score | 1 | 5 |
| Altman Z-Score | 0.49 | 1.95 |
| LTL to 5YR AVG FCF | N/A | -29.52 |
| Shares Outstanding Growth 5YR AVG | 60.05% | 2.57% |